A novel SARS-CoV-2 recombinant transmitted from a patient with an acute co-infection

IF 20.9 1区生物学 Q1 INFECTIOUS DISEASES Lancet Microbe Pub Date : 2024-12-01 DOI:10.1016/j.lanmic.2024.100998

Robert Dyrdak , Sofia Stamouli , Shambhu Ganeshappa Aralaguppe , Martin Ekman , Hamzah Safari , Carlo Berg , Elin Movert , Neus Latorre-Margalef , Emmi Andersson , Magnus Gisslén , Joanna Nederby-Öhd , Åsa Sjödin Leufvén , Josette Schoenmakers , Sandra Broddesson , Ben Murrell , Jan Albert

引用次数: 0

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

从一名急性合并感染患者身上传播的新型 SARS-CoV-2 重组病毒。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Lancet Microbe Multiple-

CiteScore

27.20

自引率

0.80%

发文量

278

审稿时长

6 weeks

期刊介绍： The Lancet Microbe is a gold open access journal committed to publishing content relevant to clinical microbiologists worldwide, with a focus on studies that advance clinical understanding, challenge the status quo, and advocate change in health policy.

期刊最新文献

Aerosol transmission risk of mpox relative to COVID-19 and smallpox. Varied prevalence and asymptomatic carriage of Cryptococcus gattii in the gut of Chinese populations. Wastewater surveillance for early warning of COVID-19 outbreaks in long-term care facilities. WHO world malaria report 2024. Safety and immunogenicity of a bivalent Ebola virus and Sudan virus ChAdOx1 vectored vaccine in adults in the UK: an open-label, non-randomised, first-in-human, phase 1 clinical trial.